Winship Cancer Institute - Emory University

Seeing over 17,000 patients a year, Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated comprehensive cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.

 

2024 ASCO® Annual Meeting Insights Hub
J

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvant Datopotamab Deruxtecan for High-Risk Stage 2/3 BC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
221 views
June 13, 2024

Chapters

I-SPY 2.2 Trial Design Overview

00:00

Dato-DXd Treatment Results & Future Plans

04:01

Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Videos
18:39

AI in Multiple Myeloma: Recent Findings and Opportunities

Winship Cancer Institute - Emory University

A. Madabhushi

74 views
13:27

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

307 views
13:21

ESMO 2024 Insights: Neoadjuvant Chemo Followed by Surgery & Post-Ope…

2024 ESMO Annual Meeting Insights Hub

N. Saba

58 views
05:06

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Br…

2024 ASCO® Annual Meeting Insights Hub

M. Bhave

464 views
09:30

ASCO® 2024 Insights: "EMBER Study - Imlunestrant, an Oral SERD, in C…

2024 ASCO® Annual Meeting Insights Hub

M. Bhave

87 views
07:02

ASCO® 2024 Insights: "postMONARCH Trial - Abemaciclib + Fulvestrant …

2024 ASCO® Annual Meeting Insights Hub

K. Kalinsky

356 views
21:12

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

1.0K views
07:20

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvan…

2024 ASCO® Annual Meeting Insights Hub

J. Meisel

221 views
16:52

Updates on Myeloproliferative Neoplasms Including CML

Winship Cancer Institute - Emory University

A. Hunter

138 views
11:02

Multiple Myeloma: Clinical Challenges for the Community Clinician

Winship Cancer Institute - Emory University

N. Joseph

257 views
08:36

ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligible M…

Insights from 2023 ASH Annual Meeting

N. Joseph

463 views
15:13

SABCS 2023 Insights: "5-Year Outcomes of the IDEA Trial - ET Without…

Insights from 2023 SABCS

R. Jagsi

509 views
13:38

ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuximab V…

Insights from 2023 ASH Annual Meeting

S. Castellino

34 views
09:19

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for Prem…

Insights from 2023 SABCS

K. Kalinsky

1.8K views
10:03

Case Studies of a Patient With HR+/HER2- mBC: Treatment Approach in …

Winship Cancer Institute - Emory University

D. Smith-Graziani

214 views
07:50

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Toler…

Oncology Data Advisor

K. Kalinsky

1.0K views
13:59

SOHO 2023 DEBATE: Against Allogeneic Transplantation for AML Patient…

SOHO 2023 Eleventh Annual Meeting

E. Waller

50 views
15:28

SOHO 2023: Next Generation Therapeutics (Degraders & Targeted Therap…

SOHO 2023 Eleventh Annual Meeting

A. Nooka

89 views
16:48

SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibro…

SOHO 2023 Eleventh Annual Meeting

A. Hunter

91 views
14:03

SOHO 2023 DEBATE: Smoldering MM - Personalized Time to Treat?

SOHO 2023 Eleventh Annual Meeting

S. Lonial

79 views
13:04

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

283 views
09:00

Harnessing IO in the Management of CSCC

Winship Cancer Institute - Emory University

N. Saba

105 views
09:52

ASCO® 2023 Insights: "Real-World Patient Characteristics & Treatment…

Insights from 2023 ASCO® Annual Meeting

J. Meisel

285 views
16:14

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/Recurr…

Insights from 2023 ASCO® Annual Meeting

E. Waller

113 views
15:11

Immunotherapy Trials for Nasopharyngeal Cancers

Insights from 2023 ASCO® Annual Meeting

N. Saba

402 views
05:03

ASCO® 2023 Insights: "Elranatamab in Patients With R/R MM Previously…

ecancer

A. Nooka

31 views
04:14

ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fields Th…

ecancer

T. Leal

242 views
13:26

The Promise of Oral SERDs for Breast Cancer: Brief Review/Update

Winship Cancer Institute - Emory University

M. Bhave

68 views
10:51

Optimising Chemoradiation to Reduce Pneumonitis Risk in Patients Wit…

Winship Cancer Institute - Emory University

N. McCall

182 views
14:22

Defining and Identifying HER2-Low Breast Cancer

Winship Cancer Institute - Emory University

J. Meisel

279 views
23:01

Desmoid Fibromatosis: An Update on Current State of Treatment

Winship Cancer Institute - Emory University

K. Cardona

188 views
01:17

Lecture Summary - TP53 Screening in HR-MDS and Its Role in Treatment…

Winship Cancer Institute - Emory University

A. Hunter

13 views
19:02

TP53 Screening in HR-MDS and Its Role in Treatment Selection

Winship Cancer Institute - Emory University

A. Hunter

202 views
04:00

Daratumumab With Pomalidomide & Dexamethasone at 1st Relapse in R/R …

Winship Cancer Institute - Emory University

N. Joseph

234 views
09:27

ASCO 2021 Updates in Locally Advanced HNSCC: Neoadjuvant Pembro, Adj…

Winship Cancer Institute - Emory University

N. Saba

74 views
06:14

ASCO 2021 Updates in Recurrent/Metastatic H&N Cancers: Efti & Pembro…

Winship Cancer Institute - Emory University

N. Saba

49 views
19:39

ASCO 2021 Updates on Preoperative Therapy in BC: Why Surgery Is Not …

Winship Cancer Institute - Emory University

K. Kalinsky

596 views